ClinVar Miner

Submissions for variant NC_012920.1(MT-TP):m.15958A>T

dbSNP: rs2068750239
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Mitochondrial Disease Nuclear and Mitochondrial Variant Curation Expert Panel, ClinGen RCV001090167 SCV005088554 uncertain significance Mitochondrial disease 2024-04-23 reviewed by expert panel curation The m.15958A>T variant in MT-TP has been reported in one individual from one family to date (PMID: 27816331), in a boy with myopathy and failure to thrive. Muscle biopsy showed ragged red fibers, COX-deficient fibers, mitochondrial proliferation, complex I deficiency, and complex IV deficiency. The variant was present at 94% heteroplasmy in muscle, 78% in urine, 48% in skin fibroblasts, 9% in blood, and was undetectable in buccal sample. The variant was undetectable in urine, blood, and buccal sample from his mother (PM6_supporting, PMID: 27816331). The computational predictor MitoTIP suggests this variant is pathogenic (93.8 percentile) and HmtVAR predicts it to be pathogenic score of 0.4 (PP3). This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). Single fiber testing showed higher levels of the variant in COX negative fibers (96.10% ± 1.66) than in COX positive fibers (68.78% ± 18.11), p=0.0002 (PS3_supporting, PMID: 32419253). In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on April 23, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PS3_supporting, PM6_supporting, PM2_supporting, PP3.
Service de Génétique Médicale, Centre Hospitalier Universitaire de Nice-Université Côte d'Azur RCV001090167 SCV001244369 pathogenic Mitochondrial disease 2019-10-01 no assertion criteria provided in vitro Exercise intolerance, myalgia, amyotrophy and mild weakness in the lower limbs, intermittent unilateral ptosis, dysarthria, failure to thrive

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.